GH Research Competitors and Similar CompaniesClear all

Elicio Therapeutics's competitors and similar companies include Autifony Therapeutics, Calypso Biotech and Actavis.

	Elicio Therapeutics Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers.	Autifony Therapeutics Autifony Therapeutics is a biotechnology company that develops new drugs to treat serious disorders of the central nervous system.	Calypso Biotech Calypso Biotech is an immunotherapy biotech company	Actavis Actavis is a pharmaceutical products manufacturing company.
Founding Date	Founding Date 2011	Founding Date 2011	Founding Date 2013	Founding Date 1984
Type	Type Public	Type Private	Type Private	Type Subsidiary
Tags	Tags Technology drug development oncology pharma therapy	Tags Healthcare biotech drug development mental health pharma therapy	Tags Technology biotech drug development pharma therapy	Tags clinical research drug development mental health pharma therapy
Locations	Locations Cambridge, US HQ	Locations Stevenage, GB HQ Padova, IT	Locations Plan-les-Ouates, CH HQ Amsterdam, NL	Locations Beograd, RS HQ
Employees	Employees 22	Employees 3017% decrease	Employees 12	Employees 59
Financial
Net income	Net income ($39.6m) (FY, 2025)	Net income £16.2m (FY, 2018)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 12.3m (about 11 years ago)	Latest funding round $ 22.8m (over 7 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 150.3m	Total funding raised $ 24.2m	Total funding raised $ 26.1m	Total funding raised N/A